Glycaemic control with modified intensive insulin injections (MII) using insulin pens and premixed insulin in children with type-1 diabetes: A randomized controlled trial

Journal of Tropical Pediatrics

Volumn 52, Issue 4, 2006, Pages 276-281

  Soliman, Ashraf T ^a   Omar, Magdi ^a   Rizk, Mostafa M ^a   El Awwa, Ahmad ^a   AlGhobashy, Fatma M ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ISOPHANE INSULIN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DRUG MIXTURE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INJECTION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TREATMENT DURATION;

ADOLESCENT; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; LONGITUDINAL STUDIES; MALE;

EID: 33748104407     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmk005     Document Type: Article

References (44)

1. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
2. DCCT Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994;125:177-88.
3. American Diabetes Association. Implication of United Kingdom Prospective Diabetes Study. (Position Statement) Diabetes Care 2003;26(Suppl. 1): S28-S32.
4. American Diabetes Association Position Statement. Implications of the Diabetes Control and Complication Trial. Diabetes 1993;42:1555.
5. American Diabetes Association. Implication of the Diabetes Control and Complication Trial (Position Statement) Diabetes Care 2003;26(Suppl. 1):S25-27.
6. White NH, Cleary PA, Dahms W, et al. Beneficial effects of intensive therapy of diabetes during adolescence: Outcomes after the conclusion of Diabetes Control and Complications Trial (DCCT). Diabetes Control and Complication Trial DCCT/Epidemiology of diabetes intervention and complications. J Pediatr 2001;139:804-12.
7. Ohkubo Y, Kisikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: A randomized prospective 6-years study. Diabetes Res Clin Pract 1995;28:103-17.
8. Dahl-Jorgensen K. Modern insulin therapy in children and adolescent. Acta Paediatr 1999;427:25-30.
9. Woodworth JR, Howey DC, Bowsher RR. Establishment of time action profiles for regular and NPH insulin using phamacodynmic modeling. Diabetes Care 1994:17:64-9.
10. Mohn A, Dunger DB. Insulin therapy in children and adolescents with type 1 diabetes. Current Pediatrics 1999;9:158-63.
11. Litton J, Rice A, Friedman N, et al. Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. J Pediatr 2002;141:490-95.
12. Di Meglio LA, Pottorff TM, Boyd SR, et al. A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 2004;145: 380-84.
13. Fox LA, Buckloh LM, Smith SD, et al. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care 2005; 28:1277-81.
14. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri G. Insulin pump therapy. Diabetes Care 2003;26:1079-87.
15. Plotnick LP, Clark LM, Brancati FL, et al. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 2003;26:1142-46.
16. Wysocki T, Greco P. Self management of childhood diabetes in family context. In: Gochman DS (ed.). Handbook of Health Behavior Research. Vol. II. New York, Plenum Press, 1997, pp. 169-87.
17. Buckingham BA, Paguntalan H, Fassl B, et al. Continuous subcutaneous insulin infusion (CSII) in children under five years of age. Diabetes 2001; 50(Suppl 2):428.
18. Bode BW, Gross TM, Thornton KR, et al. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: A pilot study. Diabetes Res Clin Pract 1999;46:183-90.
19. Doyle EA, Weinzimer SA, Steffen AT, et al. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004;27:1554-58.
20. Attia N, Saif R, Al Ashwal A, et al. Feasibility of applying DCCT recommendation in adolescents with insulin-dependent diabetes in Saudi Arabia. Ann Saudi Med 1997;17:659-61.
21. Tamborlane WV, Grey M. Is strict glycaemic control of diabetes necessary and feasible in most children and adolescents? J Clin Endocrinol Metab 2000;85:515-18.
22. Silverstein JH, Malone JI. Strict glycaemic control is necessary but not practical in most children with type 1 diabetes. J Clin Endocrinol Metab 2000;85:518-22.
23. DCCT Research Group. Expanded role of the dietitian in the Diabetes Control and Complications Trial. Implication for clinical practice. J Am Diet Assoc 1993;93:758-64.
24. Muhlhauser I, Berger M. Diabetes education and insulin therapy: When will they ever learn? J Intern Med 1999;233:321-6.
25. Bohannon N J.V. Insulin delivery using pen devices; Simple-to-use tools may help young and old alike. Postgrad Med 106:57-68.
26. Smits JPH, Schop C, Blok G. A comparative study between two insulin pen injection devices. Acta Therapeutica 1993;19:15-22.
27. Daugherty KK. Review of insulin therapy. J Pharm Pract 2004;17:10-19.
28. Boehm BO, Home PD, Behrend C, et al. Premixed insulin aspart 30 vs premixed human insulin 30/70 twice daily: A randomized trial in type 1 and type 2 diabetic patients. Diabet Med 2002;19:393-99.
29. Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: Meta-analysis of randomised controlled trials. BMJ 2002;324:705.
30. Hanaie-Broutin H, Melki V, Bessieres-Lacombe S, et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment. Diabetes Care 2000;23:1232-35.
31. Ratner RE, Hirsch IB, Neifing JL, et al. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. Diabetes Care 2000;23:639-43.
32. Raskin P, Klaff L, Bergenstal R, et al. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type-1 diabetes. Diabetes Care 2000;23:1666-71.
33. Maquart FX, Gillery P, Bernard JF, et al. A method for specifically measuring haemoglobin Alc with a disposable commercial ion exchange column. Clin Chem Acta 1980;108:329-32.
34. Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: Meta-analysis of randomised controlled trials. BMJ 2002;324:705.
35. Home PD, Capaldo B, Burrin JM, et al. A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: Improved control with CSII. Diabetes Care 1982;5:466-71.
36. Dahl-Jørgensen K, Brinchman-Hansen O, Hanssen KF, et al. Effect of near-normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: The Oslo study. BMJ 1986;293:1195-9.
37. Schiffrin A, Belmonte MM. Comparison between continuous subcutaneous insulin infusion and multiple injections of insulin. A one-year prospective study. Diabetes 1982;31:255-64.
38. Schiffrin AD, Desrosiers M, Aleyassine H, et al. Intensified insulin therapy in the type 1 diabetic adolescent: A controlled trial. Diabetes Care 1984; 7:107-13.
39. Helve E, Koivisto VA, Lehtonen A, et al. A crossover comparison of continuous insulin infusion and conventional injection treatment of type 1 diabetes. Acta Med Scand 1987;221:385-93.
40. Marshall SM, Home PD, Taylor R, et al. Continuous subcutaneous insulin infusion versus injection therapy: A randomized cross-over trial under usual diabetic clinic conditions. Diabet Med 1987;4:521-5.
41. Bak JF, Nielsen OH, Pedersen O, et al. Multiple insulin injections using a pen injector versus insulin pump treatment in young diabetic patients. Diabetes Res 1987;6:155-8.
42. Saurbrey N, Arnold-Larsen S, Møller-Jensen B, et al. Comparison of continuous subcutaneous insulin infusion with multiple insulin injections using the NovoPen. Diabetic Med 1988;5:150-3.
43. Hannaire-Broutin H, Melki V, Bessieres-Lacombe S, et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: A randomized study. Diabetes Care 2000; 23:1232-5.
44. Hirsch IB, Bode BW, Garg S, et al. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII Diabetes Care 2005;28:533-8.